跳至主要内容
临床试验/NCT00880932
NCT00880932已完成不适用

The Effect of Customized Alerts Versus Generic Alerts for the Prescription of Warfarin and NSAID

University of Pennsylvania2 个研究点 分布在 1 个国家目标入组 1,865 人开始时间: 2006年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,865
试验地点
2
主要终点
Decreased rate of prescription of the combination of warfarin and NSAID

研究概览

简要总结

The hypothesis is that a newly formatted electronic alert that requires the prescriber to pause and enter a specific "reason for override" on this alert, will cause prescribers in the intervention group to be significantly less likely to prescribe the combination of warfarin and NSAID than prescribers in the control group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Single (Care Provider)

入排标准

性别
All
接受健康志愿者

入选标准

  • All resident physicians (RP) and nurse practitioners (NP) involved in inpatient care at two hospitals of the University of Pennsylvania

排除标准

  • 未提供

结局指标

主要结局

Decreased rate of prescription of the combination of warfarin and NSAID

时间窗: 17 months

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Warfarin and Non-Steroidal Anti-Inflammatory Drugs... | 临床试验